Platelet vitamin D receptor is reduced in osteoporotic patients. by D’Amelio, P et al.
Panminerva Med. 2012 Sep;54(3):225-31. 
Platelet vitamin D receptor is reduced in osteoporotic patients. 
D'Amelio P, Cristofaro MA, De Vivo E, Ravazzoli M, Grosso E, Di Bella S, Aime M, Cotto 
N, Silvagno F, Isaia G, Pescarmona GP. 
Source 
Section of Gerontology, Department of Surgical and Medical Disciplines, University of Turin, Turin, Italy. 
patrizia.damelio@unito.it 
Abstract 
AIM: 
It is well known that vitamin D plays an important role in maintaining bone homeostasis and in regulating 
calcium absorption. The active form of vitamin D interacts with its receptor the VDR that is expressed in 
multiple tissues and it is involved in platelets (PLTs) function. In the present study we evaluate PLTs' VDR 
expression in osteoporotic as opposed to healthy subjects. 
METHODS: 
We enrolled in the study 77 women with postmenopausal osteoporosis, 33 healthy women of childbearing 
age, 49 healthy men, and 11 healthy women matched with patients for age and postmenopausal period. 
Thirty-nine patients had had one femoral fracture occurred after the age of fifty and attributable to primary 
osteoporosis. Bone mineral density, markers of bone metabolism and VDR levels were measured in all the 
subjects. 
RESULTS: 
Our data show that VDR level is lower in patients as respect to controls and is positively correlated with bone 
density, but not with markers of bone metabolism. We also found a decrease in the phosphorus levels in 
patients without differences in vitamin D levels and in the dietary calcium intake. 
CONCLUSION: 
The lower VDR expression in osteoporotic could indicate a lower ability to respond to vitamin D, and could 
be the explanation of the increase in the PTH and decrease in the phosphorus levels in patients with respect 
to controls. 
 
